Stryker SYK
NYSE SYK
$275.50 -0.93 (-0.34%)
As of: Sep 9, 2026 · 3:59 PM EDT

Stryker (SYK) Cash from Investing Activities (2009 - 2026)

Stryker's (SYK) quarterly Cash from Investing Activities came in at -$639.0 million in Q2 2026, down 514.42% year-over-year from $154.2 million in Q2 2025, and down 245.41% quarter-over-quarter from -$185.0 million in Q1 2026.

Analysis

Stryker (SYK) Cash from Investing Activities (2009 - 2026) Analysis & Trends

Stryker (SYK) has reported Cash from Investing Activities for 18 consecutive years, with -$639.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Cash from Investing Activities fell 514.42% year-over-year to -$639.0 million in Q2 2026; TTM through Jun 2026 was -$1.5 billion, a 78.41% increase from a year earlier, with the FY2025 full-year figure at -$4.9 billion, down 62.2% from the prior year.
  • Cash from Investing Activities was -$639.0 million for Q2 2026 at Stryker, down from -$185.0 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $72.0 million in Q3 2022 and troughed at -$4.1 billion in Q1 2025.
  • A 5-year average of -$698.7 million and a median of -$244.0 million in 2024 frame the typical range for Cash from Investing Activities.
  • The widest YoY moves for Cash from Investing Activities: up 129.15% in 2022, down 2693.75% in 2022.
  • Over 5 years, Cash from Investing Activities stood at -$162.0 million in 2022, then advanced by 6.17% to -$152.0 million in 2023, then plunged by 99.34% to -$303.0 million in 2024, then retreated by 0.66% to -$305.0 million in 2025, then tumbled by 109.51% to -$639.0 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$639.0 million (Q2 2026), -$185.0 million (Q1 2026), and -$305.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn -673.00 Mn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn -26.60 Mn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn -1.62 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn -639.00 Mn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn -1.96 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn -193.20 Mn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -222.00 Mn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 329.80 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn -108.50 Mn
10 Zimmer Biomet Holdings 18.20 Bn 17.79 Bn 1.54 Bn -190.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -639.00 Mn
Mar 31, 2026 -185.00 Mn
Dec 31, 2025 -305.00 Mn
Sep 30, 2025 -321.00 Mn
Jun 30, 2025 -104.00 Mn
Mar 31, 2025 -4.14 Bn
Dec 31, 2024 -303.00 Mn
Sep 30, 2024 -2.17 Bn
Jun 30, 2024 -117.00 Mn
Mar 31, 2024 -408.00 Mn
Dec 31, 2023 -152.00 Mn
Sep 30, 2023 -145.00 Mn
Jun 30, 2023 -533.00 Mn
Mar 31, 2023 -132.00 Mn
Dec 31, 2022 -162.00 Mn
Sep 30, 2022 72.00 Mn
Jun 30, 2022 -152.00 Mn
Mar 31, 2022 -2.68 Bn
Dec 31, 2021 -314.00 Mn
Sep 30, 2021 -247.00 Mn